Today, reliable ADHD diagnosis usually requires four to six hours of interviews following semi-structured questionnaires, and final accuracy in this classical approach typically ranges between 85 to 90 percent.
As part of a broader collaboration with Ping An Group, Braingaze set out to explore how these diagnostic testing solutions could be offered to Chinese clinicians running into possible cases of ADHD.
After initial technology compatibility validations, the three firms are now finishing configuration of a comprehensive solution package that will allow Ping An Group to perform objective and convenient testing for ADHD patients.
"Based on the next-generation equipment available on the mobile terminals, we hope to bring more convenient and effective intervention diagnosis and treatment solutions for children with ADHD.
The company offers a patented, scientifically and clinically validated biomarker-based decision support system for early and objective diagnosis of ADHD and Alzheimer's disease, as well as digital treatment to improve patients' cognitive health.